BENDAMUSTINE (B), FOLLOWED BY OBINUTUZUMAB (G) AND VENETOCLAX (A) IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): CLL2-BAG TRIAL OF THE GERMAN CLL STUDY GROUP (GCLLSG)

Authors :: Othman Al-Sawaf
Michael Kneba
Till Seiler
Petra Langerbeins
A. M. Fink
Sandra Robrecht
C M Wendtner
Jasmin Bahlo
Paula Cramer
Michael Hallek
Kirsten Fischer
S. Stilgenbauer
Matthias Ritgen
L. Fischer von Weikersthal
Anja Engelke
Barbara Eichhorst
J. von Tresckow
Karl-Anton Kreuzer
Holger Hebart
Source :: Hematological Oncology. 35:25-27
Publication Year :: 2017
Publisher :: Wiley, 2017.

Full Text Access

Tools